DeepCure
Boston
About DeepCure
DeepCure builds an AI engine for small-molecule drug discovery. The company is utilizing AI-driven drug discovery to expedite the advancement of groundbreaking, first-in-class precision therapeutics targeting areas with unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $71.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: deepcure.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Product Research
Social Profiles
Canonical: https://fsome.com/organization/deepcure-72607 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.